back to US directory
us clinical guidance

Adult immunization review

CDC/ACIP age-based, risk-based, pregnancy, catch-up and shared-decision vaccination workflow for US adults.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults aged 19 years or older receiving routine, catch-up or risk-based vaccination in the United States. This page is a workflow around the live CDC/ACIP schedule, not a copied vaccine table, because recommendations, products and addenda change between annual publications.
sources for this section:CDC immunization schedules

The Bottom Line

  • Review vaccination at every adult encounter using the current age table, medical-indication table and vaccine-specific notes; age alone is insufficient for many hepatitis, pneumococcal, meningococcal, RSV, mpox and travel decisions.
  • Assess pregnancy, immune status, asplenia, chronic disease, prior vaccines and infections, occupation, housing, sexual and injection exposure, travel and anticipated immunosuppression before selecting products.
  • Complete unfinished primary or catch-up series using valid prior doses rather than restarting, and apply minimum intervals only when an accelerated schedule is clinically justified.
  • Distinguish routinely recommended vaccination from shared clinical decision-making: the latter requires an individualized benefit and risk discussion and is not a weaker safety standard.
  • Use each visit to reduce missed opportunities, including influenza-season, prenatal, post-splenectomy, chronic-disease and medication-start encounters, while checking current federal and jurisdictional recommendations.
sources for this section:CDC immunization schedules

Practical clinical workflow

1
Reconcile state registry, pharmacy, prior-system and patient records, then identify doses with valid dates and products and flag uncertain live-vaccine or series histories for source-specific resolution.
2
Screen for pregnancy, immunocompromise, splenic function, renal and hepatic disease, diabetes, cardiopulmonary disease, smoking, sexual exposure, injection use, occupation, travel and congregate living.
3
Consult the live CDC adult schedule and notes, choose the indicated formulation and series, and check coadministration, minimum interval and timing around biologic, chemotherapy or transplant treatment.
4
Give the current Vaccine Information Statement, document informed discussion and administration, update the registry and provide a written date for every remaining dose.
5
At follow-up, complete the series, evaluate significant adverse events and revisit risk when health status, pregnancy, medicines, travel or ACIP guidance changes.
sources for this section:CDC immunization schedules

Safety boundaries and escalation

  • Avoid live vaccine in pregnancy and in the forms of immunocompromise listed by ACIP; vaccinate before planned immunosuppression when timing permits and coordinate post-transplant or oncology schedules with specialists.
  • Do not treat age, egg allergy, anticoagulation or a prior nonspecific reaction as a blanket contraindication; use the vaccine-specific precaution and administration guidance.
  • Manage anaphylaxis immediately, prevent and manage syncope, and report qualifying events; distinguish temporal association from a proven contraindication before withholding future protection.
  • Check timing after blood products, antiviral medicines and a recent infection when relevant, because these can affect selected live or respiratory-virus vaccines differently.
sources for this section:CDC immunization schedules

Localization

ACIP recommendations are national, but pharmacy scope, registry access, mandates and payment vary by state and payer. The live CDC portal and its July 2, 2025 addenda were directly rechecked on 2026-08-20; use the live schedule and notes at every encounter because interim recommendations can change.
sources for this section:CDC immunization schedules

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Centers for Disease Control and PreventionHealthcare Professionals: Immunization SchedulesCurrent CDC/ACIP child, adolescent and adult schedule portal; July 2, 2025 addenda directly rechecked 2026-08-20 路 updated 2025-07-02 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.